Patents Assigned to Pierrre Fabre Medicament
  • Anti-CXCR4 antibody and its use for the detection and diagnosis of cancer
    Patent number: 9518120
    Abstract: The present invention provides a novel, isolated anti-CXCR4 antibody for use in the diagnosis of cancer. In particular, the antibody of the invention recognizes monomeric and homodimeric CXCR4, but not heterodimeric CXCR4.
    Type: Grant
    Filed: July 30, 2012
    Date of Patent: December 13, 2016
    Assignee: Pierrre Fabre Medicament
    Inventors: Christine Klinguer-Hamour, Alexandra Jouhanneaud, Marie-Claire Janin-Bussat